Spruce Biosciences, Inc.
Assets & Liabilities
| Period | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| Sep 2019 | — | — | $4.8M |
| Dec 2019 | $7.5M | $4.7M | $3.9M |
| Mar 2020 | — | — | $41.4M |
| Jun 2020 | — | — | $36.6M |
| Sep 2020 | $14.5M | $78.5M | $72.2M |
| Dec 2020 | $13.5M | $162.9M | $157.2M |
| Mar 2021 | $13.3M | $154.0M | $148.6M |
| Jun 2021 | $13.3M | $143.4M | $78.3M |
| Sep 2021 | $15.4M | $135.1M | $58.4M |
| Dec 2021 | $15.1M | $126.5M | $42.7M |
| Mar 2022 | $14.7M | $115.0M | $23.3M |
| Jun 2022 | $15.4M | $104.5M | $47.2M |
| Sep 2022 | $16.8M | $95.3M | $21.6M |
| Dec 2022 | $17.2M | $85.6M | $24.5M |
| Mar 2023 | $31.1M | $139.1M | $73.9M |
| Jun 2023 | $29.4M | $126.0M | $97.5M |
| Sep 2023 | $27.6M | $113.0M | $98.8M |
| Dec 2023 | $27.4M | $103.9M | $96.3M |
| Mar 2024 | $20.9M | $87.5M | $81.2M |
| Jun 2024 | $16.4M | $75.5M | $69.7M |
| Sep 2024 | $13.5M | $65.1M | $60.1M |
| Dec 2024 | $16.4M | $45.2M | $38.8M |
| Mar 2025 | $16.3M | $31.6M | $25.6M |
| Jun 2025 | $8.6M | $21.8M | $16.4M |
| Sep 2025 | $9.9M | $15.3M | $10.7M |
| Dec 2025 | $10.5M | $53.0M | $48.9M |
| Mar 2026 | $21.5M | $56.2M | $54.1M |
| Jun 2026 | $19.1M | $102.9M | $96.3M |